Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on May 5, 2020. The report discloses the closing of a public offering of common stock that occurred on April 30, 2020.
Key Financial Metrics
- Capital Raised: The Company sold 7,500,000 shares of common stock.
- Offering Price: $1.00 per share.
- Gross Proceeds: $7,500,000 (prior to deducting underwriting discounts, commissions, and offering expenses).
- Net Proceeds: The filing text does not provide a clear value for net proceeds after expenses.
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational or balance sheet metrics.
Material Changes
The primary material change is the increase in cash assets resulting from the equity offering. The Company successfully closed the underwritten public offering previously announced, adding $7.5 million in gross capital to its balance sheet.
Guidance, Outlook, and Risks
The filing contains no specific forward-looking guidance, management commentary on future operations, or discussion of risks and contingencies beyond the standard disclosure of the offering closing. No unusual items were reported in this specific document.
Investor Verification Checklist
- Verify the exact amount of underwriting discounts and offering expenses to determine net cash proceeds.
- Confirm the total number of shares outstanding post-offering to assess dilution impact.
- Review the attached press release (Exhibit 99.1) for details on the intended use of proceeds.
- Check subsequent filings for the impact of this capital raise on the Company's liquidity position.